Plant ID: NPO2669
Plant Latin Name: Bowdichia Virgilioides
Taxonomy Genus: Bowdichia
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
149685
Plant-of-the-World-Online:
n.a.
Brazil
Ingredient ID: NPC94045
Ingredient ID: NPC83831
Ingredient ID: NPC80710
Ingredient ID: NPC76145
Ingredient ID: NPC71853
Ingredient ID: NPC52691
Ingredient ID: NPC479016
Ingredient ID: NPC479015
Ingredient ID: NPC479014
Ingredient ID: NPC479013
Ingredient ID: NPC479012
Ingredient ID: NPC479011
Ingredient ID: NPC479010
Ingredient ID: NPC479009
Ingredient ID: NPC479008
Ingredient ID: NPC47844
Ingredient ID: NPC476464
Ingredient ID: NPC4152
Ingredient ID: NPC35543
Ingredient ID: NPC33090
Ingredient ID: NPC309399
Ingredient ID: NPC30443
Ingredient ID: NPC303196
Ingredient ID: NPC283908
Ingredient ID: NPC283655
Ingredient ID: NPC279666
Ingredient ID: NPC27184
Ingredient ID: NPC270818
Ingredient ID: NPC261447
Ingredient ID: NPC259733
Ingredient ID: NPC253722
Ingredient ID: NPC253481
Ingredient ID: NPC243591
Ingredient ID: NPC231730
Ingredient ID: NPC229403
Ingredient ID: NPC219945
Ingredient ID: NPC203108
Ingredient ID: NPC190810
Ingredient ID: NPC181217
Ingredient ID: NPC177574
Ingredient ID: NPC177228
Ingredient ID: NPC157403
Ingredient ID: NPC148821
Ingredient ID: NPC128248
Ingredient ID: NPC109854
Ingredient ID: NPC102467
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Enzyme | KARS1 | Lysyl-tRNA synthetase | Q15046 | CHEMBL5575 |
Therapeutic Target | Membrane receptor | SIGMAR1 | Sigma opioid receptor | Q99720 | CHEMBL287 |
Therapeutic Target | Transcription factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 88 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT01814423 | Pharmacokinetic Study of Multi-dose Chloroquine | malaria | Chloroquine (NPC476464) | NP level |
NCT01718054 | Vascular Function Intervention Trial in Sickle Cell Disease | sickle cell anemia | Chloroquine (NPC476464) | NP level |
NCT04319900 | Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT00379821 | Chloroquine Alone or in Combination for Malaria in Children in Malawi | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT02029118 | Acupoint Application in Patients With Stable Angina Pectoris (AASAP) | angina pectoris | Borneol (NPC283655) | NP level |
NCT04345406 | Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19 | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT00677833 | Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT01438177 | Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma | multiple myeloma | Chloroquine (NPC476464) | NP level |
NCT02348788 | Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT04627467 | Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID) | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT02996695 | Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT03278808 | Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis | malaria | Chloroquine (NPC476464) | NP level |
NCT00959517 | Trial of Artesunate Combination Therapy in Pakistan | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT00849602 | The Effect of Chloroquine in the Treatment of Patients With Dengue | Dengue Hemorrhagic Fever | Chloroquine (NPC476464) | NP level |
NCT02432417 | The Addition of Chloroquine to Chemoradiation for Glioblastoma, | glioblastoma multiforme | Chloroquine (NPC476464) | NP level |
NCT01941095 | A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis | rheumatoid arthritis | Chloroquine (NPC476464) | NP level |
NCT00323375 | Studies of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine | malaria | Chloroquine (NPC476464) | NP level |
NCT04349371 | Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT01777477 | Adjuvant Effect of Chloroquine on Gemcitabine | pancreatic carcinoma | Chloroquine (NPC476464) | NP level |
NCT00682578 | A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan | Plasmodium falciparum malaria;Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT00442403 | Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria | malaria | Chloroquine (NPC476464) | NP level |
NCT01023477 | Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) | breast ductal carcinoma in situ | Chloroquine (NPC476464) | NP level |
NCT02216123 | Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT04447534 | Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19 | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT01292408 | Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients | breast cancer | Chloroquine (NPC476464) | NP level |
NCT01575782 | Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer | small cell lung carcinoma | Chloroquine (NPC476464) | NP level |
NCT01205178 | G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine) | malaria | Chloroquine (NPC476464) | NP level |
NCT04333628 | Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT04360759 | Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19 | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT04303299 | Fight COVID-19 Trial | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT01078779 | The Chloroquine for Influenza Prevention Trial | influenza | Chloroquine (NPC476464) | NP level |
NCT00844207 | A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine | malaria | Chloroquine (NPC476464) | NP level |
NCT02071537 | Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors | cancer | Chloroquine (NPC476464) | NP level |
NCT01103713 | Evaluate Parasitological Clearance Rates And Pharmacokinetics Of The Combination Of Azithromycin And Chloroquine In Asymptomatic Pregnant Women With Falciparum Parasitemia In Africa | pregnancy | Chloroquine (NPC476464) | NP level |
NCT04392622 | d-Limonene +Radiation +Platinum Based Chemo for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma | xerostomia | Limonene (NPC76145) | NP level |
NCT04353336 | Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT01708876 | P. Knowlesi Trial of Artesunate-mefloquine Versus Chloroquine | malaria | Chloroquine (NPC476464) | NP level |
NCT04420247 | Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT01074905 | Study on the Treatment of Vivax Malaria | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT01659580 | Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina | angina pectoris | Borneol (NPC283655) | NP level |
NCT00082563 | Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT01100060 | A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects | malaria | Chloroquine (NPC476464) | NP level |
NCT02691910 | Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT02333890 | A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer | breast cancer | Chloroquine (NPC476464) | NP level |
NCT00972725 | Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose | AIDS | Chloroquine (NPC476464) | NP level |
NCT02563496 | A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT04368910 | Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria | malaria | Chloroquine (NPC476464) | NP level |
NCT02773979 | PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT00084240 | Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT03503058 | Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria | malaria | Chloroquine (NPC476464) | NP level |
NCT01680406 | Ethiopia Antimalarial in Vivo Efficacy Study 2012 | malaria | Chloroquine (NPC476464) | NP level |
NCT00082576 | Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT00367653 | Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria. | malaria | Chloroquine (NPC476464) | NP level |
NCT00131703 | Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women | pregnancy;malaria | Chloroquine (NPC476464) | NP level |
NCT01378286 | Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax Malaria | malaria | Chloroquine (NPC476464) | NP level |
NCT00158548 | ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan | Plasmodium falciparum malaria;Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT02378532 | The Addition of Chloroquine to Chemoradiation for Glioblastoma | glioblastoma multiforme | Chloroquine (NPC476464) | NP level |
NCT00074841 | Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT01500980 | Malaria Challenge in Healthy Volunteers | malaria | Chloroquine (NPC476464) | NP level |
NCT01546389 | Sanaria™ PfSPZ Challenge Vaccine | malaria | Chloroquine (NPC476464) | NP level |
NCT00440999 | Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria | malaria | Chloroquine (NPC476464) | NP level |
NCT00871156 | Tafenoquine/Chloroquine DDI Study | malaria | Chloroquine (NPC476464) | NP level |
NCT02389374 | A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh | malaria | Chloroquine (NPC476464) | NP level |
NCT00819390 | Chloroquine for Reducing Immune Activation in HIV- Infected Individuals | HIV infection | Chloroquine (NPC476464) | NP level |
NCT00282919 | A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
NCT00290420 | Prevention of P. Vivax Malaria During Pregnancy in Bolivia | malaria | Chloroquine (NPC476464) | NP level |
NCT01946880 | Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) | systemic lupus erythematosus | Chloroquine (NPC476464) | NP level |
NCT02698748 | Evaluating the Role of Chloroquine for Malaria Elimination | malaria | Chloroquine (NPC476464) | NP level |
NCT01290601 | Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults | malaria | Chloroquine (NPC476464) | NP level |
NCT01640574 | Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD) | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT00811096 | Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT01103063 | Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa | pregnancy | Chloroquine (NPC476464) | NP level |
NCT02001012 | P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine | malaria | Chloroquine (NPC476464) | NP level |
NCT00224978 | Chloroquine for Treatment of Glioblastoma Multiforme | glioblastoma multiforme | Chloroquine (NPC476464) | NP level |
NCT00486694 | Artesunate Plus Sulfadoxine-Pyrimethamine Versus Chloroquine for Vivax Malaria | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT00118807 | Trial of the Effectiveness of AQ/AS, SP/AQ and SP/CQ for Uncomplicated Malaria in Gambian Children | malaria | Chloroquine (NPC476464) | NP level |
NCT04397679 | Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma | gliosarcoma | Chloroquine (NPC476464) | NP level |
NCT04853082 | Limonene on Regulating Metabolism-related Fatty Liver Disease (MAFLD) and Analysis of TCM Constitution | Hepatic steatosis | Limonene (NPC76145) | NP level |
NCT04351724 | Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT04351295 | Efficacy of Faviprevir in COVID-19 Treatment | COVID-19 | Chloroquine (NPC476464) | NP level |
NCT02610686 | Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam | malaria | Chloroquine (NPC476464) | NP level |
NCT00521924 | Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED) | rheumatoid arthritis | Chloroquine (NPC476464) | NP level |
NCT01376167 | Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse | Plasmodium vivax malaria | Chloroquine (NPC476464) | NP level |
NCT01443130 | Chloroquine for Malaria in Pregnancy | malaria | Chloroquine (NPC476464) | NP level |
NCT00969306 | Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients | small cell lung carcinoma | Chloroquine (NPC476464) | NP level |
NCT01894633 | Study of Whole-brain Irradiation With Chloroquine for Brain Metastases | brain disease | Chloroquine (NPC476464) | NP level |
NCT02511054 | Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B... | malaria | Chloroquine (NPC476464) | NP level |
NCT00084227 | Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America | Plasmodium falciparum malaria | Chloroquine (NPC476464) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
NCT00379821,NCT01814423,NCT00871156,NCT00959517,NCT02610686,NCT00290420,NCT01290601,NCT01500980,NCT03503058,NCT00074841,NCT00442403,NCT02001012,NCT02996695,NCT00158548,NCT00082563,NCT01205178,NCT01100060,NCT00084227,NCT00367653,NCT01378286,NCT00131703,NCT02389374,NCT00844207,NCT01546389,NCT03278808,NCT02511054,NCT02698748,NCT01443130,NCT01708876,NCT02773979,NCT01680406,NCT00118807,NCT00282919,NCT04368910,NCT00084240,NCT00682578,NCT00440999,NCT00082576,NCT00323375,NCT00677833
|
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT00224978,NCT02432417,NCT02378532
|
Pregnancy/childbirth/puerperium maternal infectionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB63 |
NCT00131703,NCT01103713,NCT01103063
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
TMEM97,SIGMAR1,TP53
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
SIGMAR1,TMEM97
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
SIGMAR1,TMEM97
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT01575782,NCT00969306
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
NCT01292408,NCT02333890
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
NCT01941095,NCT00521924
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
NCT02029118,NCT01659580
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
TMEM97,TP53
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
SIGMAR1,TP53
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
TMEM97,SIGMAR1
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04360759,NCT04420247,NCT04351295,NCT04345406,NCT04349371,NCT04319900,NCT04447534,NCT04627467,NCT04303299,NCT04333628,NCT04351724,NCT04353336
|
Malaria due to Plasmodium vivaxDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F41 |
NCT01074905,NCT02691910,NCT00158548,NCT00811096,NCT00682578,NCT02216123,NCT02563496,NCT01376167,NCT00486694,NCT02348788,NCT01640574
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
TP53
|
Ovarian dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80 |
TP53
|
Bulimia nervosaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B81 |
SIGMAR1
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
TP53
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
TP53
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
TP53
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
SIGMAR1
|
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
SIGMAR1
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
TP53
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
SIGMAR1
|
Sexual dysfunctionDisease Category: 17.Conditions related to sexual healthDisease ICD-11 Code: HA00-HA01 |
SIGMAR1
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
SIGMAR1
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
TP53
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
SIGMAR1
|
SomnolenceDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG42 |
SIGMAR1
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
TP53
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TP53
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TP53
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
SIGMAR1
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
SIGMAR1
|
CoughDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD12 |
SIGMAR1
|
Intellectual development disorderDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD90 |
SIGMAR1
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TP53
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
TP53
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
SIGMAR1
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
TP53
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
SIGMAR1
|
Epileptic encephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A62 |
SIGMAR1
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
TP53
|
Immune system diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01-4B41 |
SIGMAR1
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TP53
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
TP53
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
TP53
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
TP53
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
TP53
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
TP53
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
TP53
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
TP53
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
TP53
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
SIGMAR1
|
Neurobehavioral disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00-8A0Z |
SIGMAR1
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
TP53
|
XerostomiaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA02.1 |
NCT04392622
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
NCT01078779
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT02071537
|
Ductal carcinoma in situ of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65.2 |
NCT01023477
|
Other specified non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92.Y |
NCT04853082
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT01718054
|
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT00819390
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT00972725
|
Brain diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70-8E61 |
NCT01894633
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT01438177
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
NCT01946880
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT01777477
|
Dengue with warning signsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D21 |
NCT00849602
|
GliosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9RC8 |
NCT04397679
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
TP53
|
Polycystic ovary syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80.1 |
TMEM97
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
TMEM97
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
TMEM97
|